GlassScriptPhysician profile
John A Goncalves
NPI 1639150949
$332,051.16
in general payments reported to CMS, 2019-2025
21 companies · $5,453 in 2025
The $5,453 reported for 2025 was more than what 83% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123K · 2020: $49K · 2021: $64K · 2022: $40K · 2023: $32K · 2024: $18K · 2025: $5,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $43K · Food and Beverage: $6,524 · Travel and Lodging: $6,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,845.00 |
| Food and Beverage | $6,524.15 |
| Travel and Lodging | $6,204.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $170,198.98 | 2019-2020 | |
| Medtronic, INC. | $118,151.59 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Simulus |
| Baxter Healthcare | $27,773.48 | 2021-2022 | |
| Atricure, INC. | $5,917.43 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Edwards Lifesciences Corporation | $4,033.61 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| W. L. Gore & Associates, INC. | $1,736.27 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Artivion, INC. | $997.80 | 2022-2025 | Amds-Ascyrus Medical |
| Abiomed | $723.78 | 2019-2024 | Impella |
| Abbott Laboratories | $588.29 | 2023-2025 | Navitor, Perclose Prostyle |
| Cook Medical LLC | $489.68 | 2021-2025 | Cook |
| Boston Scientific Corporation | $347.82 | 2019-2024 | Avvigo Guidance System |
| Clearflow INC. | $326.37 | 2019 | |
| Bolton Medical INC | $286.96 | 2021-2025 | Thoraflex Hybrid |
| Genzyme Corporation | $135.78 | 2025 | |
| Ucb, INC. | $132.95 | 2025 | Bimzelx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $115.91 | 2025 | |
| Merck Sharp & Dohme LLC | $32.33 | 2025 | Keytruda |
| Incyte Corporation | $20.45 | 2025 | Opzelura |
| Davol INC. | $14.57 | 2025 | Phasix Mesh |
| Angiodynamics, INC. | $13.61 | 2021 | |
| Amgen INC. | $13.50 | 2023 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Goncalves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.